Peer-Reviewed Articles 2019
Adamson AS, Pignone MP. Eliminating Copayments for Skin Cancer Screening: A Public Health Policy With Insufficient Evidence. JAMA Dermatol. 2019 Aug 16. [Epub ahead of print]
Kovarik C, Lee I, Ko J; Ad Hoc Task Force on Augmented Intelligence, additional members include: Adamson A, Otley C, Kvedar J, Vedak P, Huang S, Fitzgerald M, Chaudhari R. Commentary: Position Statement on Augmented Intelligence (AuI). J Am Acad Dermatol. 2019 Jun 24. [Epub ahead of print]
Matsui EC, Adamson AS, Peng RD. Time’s Up to Adopt a Biopsychosocial Model to Address Racial and Ethnic Disparities in Asthma. J Allergy Clin Immunol. 2019 Mar 30.
Wu S, Adamson AS. Cutaneous toxicity associated with enfortumab vedontin treatment of metastatic urothelial carcinoma. Dermatol Online J. 2019 Feb 15;25(2)
Singh P, Forman H, Adamson AS, Mostaghimi A, Ogdie AR, Oganisian A, Barbieri JS. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries. J Gen Intern Med. 2019 Feb;34(2):176-178.
Zeitany A, Adamson AS. Treatment of non-melanoma skin cancer in the elderly. Current Geriatrics Reports 7 (4), 216-221.
Peer-Reviewed Articles 2018
Mostaghimi A, Adamson AS. Translating Administrative Health Care Data to Treatment Decisions in Dermatology: The Blind Men and the Elephant. JAMA Dermatol. 2018 Nov 1;154(11):1256-1257.
Adamson AS, Nelson KC. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatol. 2018 Oct 10.
Albrecht J, Adamson AS, Barbieri J, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM; AADA Task Force on Drug Pricing and Transparency. Lack of an FDA indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2018 Sep 19. pii: S0190-9622(18)32594-5.
Adamson AS, Smith A. Machine Learning and Health Care Disparities in Dermatology. In press to JAMA Dermatology. 2018 Nov 1;154(11):1247-1248.
Selected Media Coverage:
AI-Driven Dermatology Could Leave Dark-Skinned Patients Behind by Angela Lashbrook The Atlantic, August 16th, 2018
Vuong KT, Walker J, Powell H, Thomas NE, Jonas DE, Adamson AS. Surgical re-excision versus observation for histologically dysplastic nevi: A systematic review of associated clinical outcomes. Br J Dermatol. 2018 Mar 23.
Greenwald E, Stein JA. Highlighting the need for prospective randomized studies on the management of dysplastic naevi. Br J Dermatol. 2018 Sep;179(3):554-555.
Powell HB, Adamson AS. Medicare Part D payments for brand and generic drugs prescribed by Dermatologists. J Am Acad Dermatol. 2018 Feb 22.
Moo-Young JA, Suarez EA, Adamson AS. Distance to pharmacy and risk of medication primary nonadherence. Dermatol Online J. 2018 Feb 15;24(2).
Song H, Adamson AS, Mostaghimi A. Trends in Medicare Spending on Topical Immunomodulators and Chemotherapies. J Am Acad Dermatol. 2018 Jan;78(1):173-175.
Peer-Reviewed Articles 2017
Adamson AS, Suarez EA, McDaniel P, Leiphart PA, Zeitany A, Kirby JS. Geographic Distribution of Nonphysician Clinicians Who Independently Billed Medicare for Common Dermatologic Services in 2014. JAMA Dermatol. 2017 Nov 22.
Adamson AS. The Economics Burden of Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:79-92.
Adamson AS, Zhou L, Baggett CD, Thomas NE, Meyer AM. Association of Delays in Surgery for Melanoma With Insurance Type. JAMA Dermatol. 2017 Nov 1;153(11).
Lott JP. Delay and Disparity in Time to Surgical Treatment for Melanoma. JAMA Dermatol. 2017 Nov 1;153(11):1094-1095.
Accompanying Author Interview:
Association of Delays in Surgery for Melanoma With Insurance Type. JAMA Dermatol. Interview with Adewole S. Adamson, MD, MPP, October 4th, 2017.
Rutherford A, Glass DA, Suarez EA, Adamson AS. Prescription-level factors associated with primary nonadherence to dermatologic medications. J Dermatolog Treat. 2017 Aug 18:1-5.
Adamson AS. Should we refer to skin as "ethnic?". J Am Acad Dermatol. Jun;76(6):1224-1225.
Adamson AS, Glass DA 2nd, Suarez EA. Patient-provider race and sex concordance and the risk for medication primary nonadherence. J Am Acad Dermatol. 2017 Jun;76(6):1193-1195.
Adamson AS, Dusetzina SB. Mohs Micrographic Surgery Use in the United States Based on Medicare Data-Reply. JAMA Dermatol. 2017 Aug 1;153(8):835.
Song H, Adamson A, Mostaghimi A. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings. JAMA Dermatol. 2017 Aug 1;153(8):755-759.
Kirby JS, Miller JJ. Generic Drugs-Changes in Cost and Challenges in Practice. JAMA Dermatol. 2017 Aug 1;153(8):745-746.
Adamson AS, Wright SW, Pandya AG. A Missed Opportunity to Discuss Racial and Gender Bias in Dermatology. JAMA Dermatol. 2017 Jan 1:153(1):110-111.
Adamson AS, Dusetzina SB. Characteristics of Medicare payments to dermatologists in 2013. JAMA Dermatol. 2017 Jan 1;153(1):95-97.
Adamson AS, Suarez EA Gorman AR. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population. JAMA Dermatol. 2017 Jan 1;153(1):49-54.
Accompanying Author Interview:
Method of Prescribing and Primary Nonadherence to Dermatologic Medication. JAMA Dermatol. Interview with Adewole S. Adamson, MD, MPP, October 26th, 2016; http://jamanetwork.com/learning/audio-player/13654976
Peer-Reviewed Articles 2016 - Previous
Liu PW, Green WL, Adamson AS. Perineal Rash and Perianal Pain. J Emerg Med. 2015 Aug;49(2):e59-60.
Adamson A, Ghoreschi K, Rittler M, Chen Q, Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ, Laurence A. Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene. PLoS One. 2013;8(3):e59367.
O'Shea JJ, Steward-Tharp SM, Laurence A, Watford WT, Wei L, Adamson AS, Fan S. Signal transduction and Th17 cell differentiation. Microbes Infect. 2009 Apr;11(5):599-611.
Adamson AS, Collins K, Laurence A, O'Shea JJ. The Current STATus of lymphocyte signaling: new roles for old players. Curr Opin Immunol. 2009 Apr;21(2):161-6.
Shet AS, Hoffmann TJ, Jirouskova M, Janczak CA, Stevens JR, Adamson A, Mohandas N, Manci EA, Cynober T, Coller BS. Morphological and functional platelet abnormalities in Berkeley sickle cell mice. Blood Cells Mol Dis. 2008 Jul-Aug;41(1):109-18.
Adamson AS (2017): The Economic Impact of Atopic Dermatitis, in Management of Atopic Dermatitis: Methods and Challenges; Fortson E, Feldman S, Strowd L, eds. Advances in Experimental Medicine and Biology. 1st edition. Page 79-92. ISBN-10: 3319648039.
Waters H, Adamson A. The Health and Economic Implications of the Use of Tanning Devices in the U.S. J Cancer Policy. February 2017.
Selected Media Coverage:
Reuters, March 2, 2017:
Tanning beds tied to U.S. health costs of $343 million a year by Lisa Rapaport.
STAT News, February 28, 2017:
Skin cancer from tanning beds costs US $343 million per year by Megan Thielking
Adewole Adamson, Ghideon Ezaz. Mississippi State Employee Wellness Programs: Opportunities and Keys to Success in Combating Obesity. Master’s Thesis. John F. Kennedy School of Government, 2011.
Adamson, Adewole. TIMP1 Regulation in CD4+ Effector T Cells. Honors Thesis. Harvard Medical School, 2011.
John J. O’Shea, Arian Laurence, Adewole S. Adamson. CD4+ T-Cell diversity. Nature Reviews Immunology. Vol 9 No 2, February 2009.